EMPIGET-M 12.5/850 EMPAGLIFLOZIN 12.5MG/METFORMIN 850MG 28’S

Empiget-M 12.5/850 is a combination medication containing Empagliflozin 12.5 mg and Metformin 850 mg, primarily used for the management of type 2 diabetes mellitus. This drug works by improving glycemic control in adults with diabetes, helping to lower blood sugar levels effectively.

Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promotes the excretion of glucose through urine, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. Together, they provide a dual mechanism of action that aids in better blood sugar management.

In Kenya, Empiget-M is particularly beneficial for patients who struggle with blood sugar levels despite lifestyle changes. It is often prescribed alongside diet and exercise to achieve optimal diabetes control. Regular use of Empiget-M can help reduce the risk of diabetes-related complications, making it a vital option for many Kenyans living with type 2 diabetes.